{"id":"W4385955746","doi":"10.1097/01.hs9.0000969496.68553.26","title":"P648: REAL-WORLD TREATMENT AND OUTCOMES OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) RECEIVING FIRST-LINE (1L) THERAPY IN THE NOVEL AGENT ERA: AN INTERNATIONAL STUDY","year":2023,"lang":"en","type":"article","venue":"HemaSphere","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Venetoclax; Obinutuzumab; Medicine; Bendamustine; Rituximab; Ibrutinib; Internal medicine; IGHV@; Chlorambucil; Fludarabine; Oncology; Population; Chronic lymphocytic leukemia; Cyclophosphamide; Leukemia; Chemotherapy; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004048246,0.0002819361,0.0004890718,0.000180583,0.00009290487,0.00003706682,0.000266765,0.00006469917,0.0002030313],"category_scores_gemma":[0.00007093926,0.0001610757,0.00006888006,0.0006622477,0.000112573,0.0001389503,0.00009588581,0.0001610986,0.00001400943],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.03346279,"about_ca_system_score_gemma":0.004671989,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.0149628,"about_ca_topic_score_gemma":0.03384544,"domain_scores_codex":[0.9977977,0.00008212127,0.000445687,0.0004745548,0.0007942836,0.0004057006],"domain_scores_gemma":[0.9985734,0.0003688062,0.0001298265,0.0006832084,0.0001279447,0.0001168489],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001122112,0.00135119,0.9738666,0.0001153335,0.0005392908,0.0001684586,0.005343317,0.001781021,0.00005216899,0.00006201037,0.0001071205,0.01549132],"study_design_scores_gemma":[0.05100516,0.003281713,0.9294131,0.0001631631,0.00006456475,0.00001318885,0.001032939,0.01413102,0.0001362906,0.00001273903,0.0005814379,0.0001646419],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9968957,0.0001094286,0.000005789782,0.0001955213,0.0001005399,0.001783896,0.000021304,0.00006420669,0.000823579],"genre_scores_gemma":[0.9971243,0.0008578816,0.0000953245,0.00007727596,0.00009849847,0.0002236309,0.00009429222,0.00004940998,0.001379422],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04988305,"threshold_uncertainty_score":0.9915966,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04471865988519662,"score_gpt":0.3370424558678615,"score_spread":0.2923237959826649,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}